HEMIATAXIA

HEMIATAXIA was reported 38 times

HEMIATAXIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
1 Protease Inhibitor [EPC] 4 0.0001
2 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
3 P2Y12 Platelet Inhibitor [EPC] 9 0.0001
4 Cytochrome P450 3A Inhibitor [EPC] 4 0.0001
5 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
6 Vitamin D3 Analog [EPC] 1 0.0000
7 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
8 Human Immunoglobulin G [EPC] 1 0.0000
9 Factor Xa Inhibitor [EPC] 9 0.0000
10 Purine Antimetabolite [EPC] 2 0.0000
11 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
12 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
13 Aldosterone Antagonist [EPC] 2 0.0000
14 Janus Kinase Inhibitor [EPC] 2 0.0000
15 Platelet Aggregation Inhibitor [EPC] 7 0.0000
16 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
17 Antiarrhythmic [EPC] 1 0.0000
18 Thiazide Diuretic [EPC] 2 0.0000
19 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
20 alpha-Adrenergic Blocker [EPC] 1 0.0000
21 Calcium [EPC] 1 0.0000
22 Loop Diuretic [EPC] 3 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
24 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
26 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
27 Estrogen [EPC] 1 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 7 0.0000
29 Expectorant [EPC] 1 0.0000
30 Kinase Inhibitor [EPC] 2 0.0000
31 beta-Adrenergic Blocker [EPC] 1 0.0000
32 Corticosteroid [EPC] 4 0.0000
33 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
34 Benzodiazepine [EPC] 2 0.0000
35 GLP-1 Receptor Agonist [EPC] 1 0.0000
36 Insulin Analog [EPC] 1 0.0000
37 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
38 Proton Pump Inhibitor [EPC] 1 0.0000